Protocol Efficacy of Mouthwashes in Experimental Gingivitis
NCT ID: NCT07270952
Last Updated: 2025-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
34 participants
INTERVENTIONAL
2023-01-11
2023-04-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%.
NCT02194023
Comparative Effects of Two Oral Antiseptics Used as an Adjuvant in the Treatment of Periodontitis
NCT06967402
Clinical and Microbiological Comparison of 0.12% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients
NCT06411522
Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque
NCT04921371
Comparative Evaluation of Guava Leaf Extract and Chlorhexidine Mouthwash in Patients With Chronic Gingivitis
NCT07059572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Material and Methods: Two different groups of subjects will be selected for this study. All study participants will have a complete periodontal charting at the initial examination visit (screening visit) and prophylaxis visit. Specifically, periodontal charting with plaque assessment (using disclosing agents), probing measurements (in mm), Gingival Index and gingival crevicular fluid (GCF) analysis (in 2 teeth) will be included.
At the first visit an oral test of the saliva using the OralDNALabs will be used to determine the bacterial load and quality. Then, a professional cleaning and polishing of the teeth will be performed.
The subjects of the Group 1 (test) will use initially a mouth rinse 3x/day with StellaLife (test group) for 1-2 min and one minute test gel (with ingredients) at the gingival margin for 1 min. for a total period of 2 weeks. Toothbrushing and flossing will not be allowed by the subjects. Subjects must avoid eating or drinking for 15 min. after the use of the mouthwash and gel. The gel should be applied for 1 min' to ' apply gel evenly using Q-tip at the neck of the teeth (cervico-gingival junction) on both sides of the teeth.
An oral test of the saliva using the OralDNALabs will be used to determine the bacterial load and quality. Then, a professional cleaning and polishing of the teeth will be performed.
Then, patients will continue the study for an additional period of 2 weeks using only Chlorhexidine mouthwash and placebo gel (without ingredients) without tooth brushing. A new test with OralDNALabs with subsequent periodontal charting will be performed and a prophylaxis visit will be included at the end of the study.
The Group 2 (control)-patients will follow similar protocol starting with use of 0.12% Chlorhexidine (Peridex®) 3x/day as mouthwash for (1-2min) and a placebo control gel (without ingredients) for a period of 2 weeks and then the subjects will start using the StellaLife mouthwash and test gel for 2 weeks (crossover study). Also, the subjects must avoid eating or drinking for 15 min. after the use of the mouthwash and gel.
The GCF will be assessed utilizing the Periotron device at the times of periodontal charting to evaluate changes in volume of GCF (from one and the same site of each participant, one posterior tooth in the maxilla and one in the mandible), comparing the baseline, 2-week, and 4- week (final) visit. The same teeth will be used in all evaluation visits for each individual patient.
The professional cleaning will be performed at the end of the study by a certified dental hygienist to achieve low levels of plaque index and gingival index.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
StellaLife
StellaLife mouthwash for 2 weeks without tooth brushing
StellaLife
StellaLife will be used in an experimental gingivitis model
Chlorhexidine
Chlorhexidine
Chlorhexidine in 2 different arms in an experimental gingivitis model
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
StellaLife
StellaLife will be used in an experimental gingivitis model
Chlorhexidine
Chlorhexidine in 2 different arms in an experimental gingivitis model
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stony Brook University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Georgios E. Romanos
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stony Brook University
Stony Brook, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB2022-00048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.